Advancing what’s next in life sciences

Pathway Bioventures is an early-stage life sciences fund for next-generation therapeutics, medical device, and diagnostics companies. We back outstanding entrepreneurs on their mission to improve human health with breakthrough life sciences innovations.

learn more about us →

Revolutionary technology.
Remarkable teams.

We focus on finding and advancing technology at the cutting-edge of biology and engineering

Genetic medicine

Genetic medicine

Novel medical devices

Novel medical devices

Targeted therapies

Targeted therapies

Advanced diagnostics

Advanced diagnostics

learn more about our strategy →

Our investments

We have been proud to participate in financings for the following revolutionary companies:

Learn more about our investments →

Ochre Bio Announces Partnership With Boehringer Ingelheim To Develop Novel Regenerative Treatments For Patients With Advanced Liver Disease

FEATURED NEWS RELEASE →